Dr. Lungren brings expertise translating cutting-edge AI
technology into valuable healthcare applications
MENLO PARK, Calif.,
May 15, 2024 /PRNewswire/ -- Cortex,
a medical technology company aiming to transform the diagnosis and
treatment of atrial arrhythmias by providing insight into each
individual patient's disease pathophysiology, today announced the
addition of clinical AI expert Dr. Matthew
Lungren to its board of directors. Lungren is Chief Data
Science Officer for Microsoft Health & Life Sciences where he
focuses on translating cutting-edge technology, including AI and
cloud services, into innovative healthcare applications.
"Dr. Lungren is a leader in his field, operating at the
intersection of artificial intelligence and practically impactful
healthcare applications," said Cortex CEO Duke Rohlen. "He brings a complementary set of
experiences, capabilities and relationships to the board that will
help us maximize the value of our Electrographic Flow mapping
capability designed with AI."
As a physician and clinical machine learning researcher, Dr.
Lungren maintains a part-time clinical practice at UCSF while also
continuing collaborative research and teaching roles as an adjunct
professor at Stanford University. Prior
to joining Microsoft, he was a clinical interventional radiologist
and research faculty at Stanford
University Medical School, where he co-founded and led the
Stanford Center for Artificial Intelligence in Medicine and Imaging
(AIMI) and then Principal for Clinical AI and Machine Learning at
Amazon Web Services in World Wide Public Sector Healthcare,
focusing on business development for clinical machine learning
technologies in the public cloud. His scientific work has led to
more than 150 publications, and he has served as co-founder and
advisor for early-stage startups as well as large fortune-500
companies on healthcare AI technology development and go-to-market
strategy.
"Cortex aims to leverage the latest in what's possible with
multimodal AI in medtech to drive new technologies and impact
patient outcomes," said Lungren. "I look forward to contributing to
the company's efforts to improve patient outcomes through providing
clear, personalized insight into the underlying drivers of atrial
fibrillation."
About Cortex
Cortex aims to transform the diagnosis and treatment of
atrial arrhythmias by providing insight into each individual
patient's disease pathophysiology. The OptiMap™ System
is a 510(k) cleared, Electrographic Flow™ mapping
solution designed with AI, enabling physicians to See What
Matters.
About Ajax Health
Ajax Health is a turnkey growth solution for
commercial-stage medtech companies. The Ajax team draws on decades
of experience as entrepreneurs, operators, and investors and
provides capital, capability, curated strategy, and creative deal
structuring to create value for its strategic partners by
accelerating product portfolio development. Ajax Health is
headquartered in Menlo Park, CA
with offices in New York City,
Los Angeles, and Austin.
Media Contact: Will Kynes,
wkynes@cortexep.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cortex-announces-appointment-of-dr-matthew-lungren-chief-data-science-officer-for-microsoft-health--life-sciences-to-its-board-of-directors-302146297.html
SOURCE Cortex